Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3163 USD | +5.43% | +0.48% | -4.09% |
Apr. 19 | Warrantee Gets Nasdaq Delisting Decision, Plans to Appeal | MT |
Apr. 18 | ADRs End Lower; Genetic Technologies Declines 23% | DJ |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 57.67 | 212 | 224.7 | 243.2 |
EBITDA 1 | -44.02 | -27.64 | -88.98 | 69.77 |
EBIT 1 | -44.48 | -27.75 | -89.84 | 52.59 |
Operating Margin | -77.13% | -13.09% | -39.98% | 21.62% |
Earnings before Tax (EBT) 1 | -48.33 | -25.8 | -97.08 | 41.3 |
Net income 1 | -48.33 | -25.8 | -97.08 | 41.3 |
Net margin | -83.81% | -12.17% | -43.2% | 16.98% |
EPS 2 | -2.416 | -1.290 | -4.853 | 1.950 |
Free Cash Flow | - | -69.21 | 188.3 | 34.66 |
FCF margin | - | -32.65% | 83.8% | 14.25% |
FCF Conversion (EBITDA) | - | - | - | 49.67% |
FCF Conversion (Net income) | - | - | - | 83.91% |
Dividend per Share | - | - | - | - |
Announcement Date | 2/7/22 | 2/7/22 | 12/6/22 | 1/31/24 |
Balance Sheet Analysis
Fiscal Period: March | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 36.5 | 70.2 | 70.4 | 139 |
Net Cash position 1 | - | - | - | - |
Leverage (Debt/EBITDA) | -0.8292 x | -2.54 x | -0.7915 x | 1.997 x |
Free Cash Flow | - | -69.2 | 188 | 34.7 |
ROE (net income / shareholders' equity) | - | 80.3% | -1,003% | -233% |
ROA (Net income/ Total Assets) | - | -12.7% | -29.7% | 14.6% |
Assets 1 | - | 203.4 | 326.4 | 282.3 |
Book Value Per Share 2 | -6.150 | 2.940 | -1.970 | 0.2000 |
Cash Flow per Share 2 | 1.280 | 0.7700 | 0.7000 | 0.0900 |
Capex 1 | 0.15 | - | 20.8 | 8.67 |
Capex / Sales | 0.25% | - | 9.27% | 3.56% |
Announcement Date | 2/7/22 | 2/7/22 | 12/6/22 | 1/31/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-4.09% | 7.09M | |
+26.79% | 28.76B | |
+11.12% | 18.83B | |
+7.59% | 13.6B | |
-2.63% | 11.99B | |
+12.76% | 11.56B | |
+19.23% | 5B | |
+4.35% | 3.55B | |
-17.73% | 3.52B | |
+17.44% | 3.36B |
- Stock Market
- Equities
- WRNT Stock
- Financials Warrantee Inc.